3 Healthcare Stocks We Steer Clear Of
Healthcare stocks have outperformed the S&P 500, but some companies face challenges. Bausch + Lomb (BLCO) has declining EPS and free cash flow margins. Envista (NVST) shows weak sales growth and profitability. Progyny (PGNY) struggles with unit sales and capital returns. All three trade at forward P/E ratios of 16.9x, 17.5x, and 11.8x respectively.
How this was made
The 30-second read
Why it matters
Highlights earnings declines and weak growth, suggesting caution for investors.
Market read
Provides a cautionary view on select healthcare stocks, but adds little new data for traders.
What to watch
Potential upside from new product launches or reimbursement changes not discussed.
Background
The article lists three healthcare companies the author advises avoiding, citing recent performance metrics.
Ticker impact
BLCO's EPS has fallen each of the past four years and free cash flow margin dropped 7.6 points over five years.
Potential further downside as investors stay cautious.
Trend of deteriorating profitability may lead to sell pressure.
NVST's sales growth slowed to 3.4% annually and EPS fell 7% yearly, indicating underperformance.
Likely modest price decline or flat performance.
Below‑industry growth and falling EPS may deter buyers.
PGNY's unit sales have stagnated and revenue remains low at $1.31B, with low ROIC.
Possible downside risk if growth does not improve.
Small revenue base and weak capital efficiency raise risk.
Market effects
Healthcare sector may face heightened scrutiny as investors weigh regulatory risks and slowing growth in eye‑care, dental and fertility segments.
U.S. healthcare stocks could see broader weakness, potentially dragging related ETFs.
Limited, primarily affects U.S. healthcare equities.
Counterpoint
Some investors may see the low valuations as buying opportunities if turnaround initiatives succeed.
Key entities
- companyBausch + Lomb
Eye‑care products maker (ticker BLCO) with falling earnings.
- companyEnvista Holdings
Dental products company (ticker NVST) with slowing sales.
- companyProgyny
Fertility benefits provider (ticker PGNY) with stagnant unit sales.
